Introduction
Cryptosporidium parvum is a common cause of diarrhoea in immunocompetent individuals. In immunodeficient subjects, cryptosporidiosis may lead to life-threatening chronic diarrhoea and, because of the incidence of AIDS, it is a public health concern in developing countries where AIDS is endemic. 1, 2 Of the many chemotherapeutic and immunotherapeutic agents tested in recent years, few have shown anti-cryptosporidial activity. 3, 4 Infectious relapses are often observed after anti-cryptosporidial therapy, both in animal models and in clinical studies, primarily because parasites persist in the biliary tract, which is not reached by active agents, such as paromomycin, that are not absorbed from the digestive tract. 5 This underlines the potential interest in agents such as nitazoxanide, which has already been shown to be active in vitro and to be readily absorbed from the gut. In humans, nitazoxanide is metabolized in vivo into tizoxanide and tizoxanide glucuronide, and these are the only metabolites detected in blood samples. 6 The aim of this study was to investigate in vitro the efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide on sporozoite invasion and asexual and sexual development of C. parvum in the enterocytic cell line HCT-8. Asexual and sexual stages of parasite development were assessed by both enzyme immunoassay and immunofluorescence.
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Materials and methods
Nitazoxanide, tizoxanide and tizoxanide glucuronide were supplied by Romark Laboratories, Tampa, FL, USA. Stock solutions were prepared in co-culture medium containing 1% (v/v) dimethylsulphoxide (DMSO) at 1 g/L for nitazoxanide and tizoxanide, and 2 g/L for tizoxanide glucuronide, and frozen at -20°C until used. Final dilutions in culture wells ranged from 1 to 50 mg/L for nitazoxanide and tizoxanide, and from 1 to 100 mg/L for tizoxanide glucuronide.
HCT-8 cells (CCL-244) were obtained from the American Type Culture Collection, Rockville, MD, USA. They were maintained in culture in BHK 21 (Eagle's modified Dulbecco's) medium supplemented with 1% non-essential amino acids and 20% fetal calf serum (Gibco BRL, Gaithersburg, MD, USA) in a 5% CO 2 humidified atmosphere. HCT-8 cells were cultured in 96-well Nunclon microplates (Nunc, Naperville, IL, USA) at 1. C. parvum sporozoites were obtained from the faeces of experimentally infected calves (kindly provided by Dr Naciri, Laboratoire de Pathologie Aviaire, INRA, Nouzilly, France) as previously described. 9 Briefly, C. parvum oocysts were concentrated on a sucrose gradient and then excysted using a 1.5% taurocholate solution. Culture medium was removed from 24 h HCT-8 cultures and 100 L per well of BHK 21 medium containing 1.5-2 ϫ 10 5 freshly isolated sporozoites was added to cell monolayers for 2 h at 37°C. Two hundred microlitres of BHK 21 medium supplemented with paraminobenzoic acid 4 mg/L (Sigma, St Louis, MO, USA), ascorbic acid 35 mg/L (Sigma), glucose 25 mmol/L (Merck, Darmstadt, Germany), insulin 100 IU/L (Novo Nordisk Pharmaceutique, BoulogneBillancourt, France), HEPES 15 mmol/L (Sigma), streptomycin 500 mg/L (Gibco BRL), penicillin 10 5 IU/L (Gibco BRL) and fetal calf serum 20% (v/v) was added to each well, and cells were cultured for an additional 46 h. 10, 11 Enzyme immunoassay (EIA) for the detection of C. parvum in HCT-8 cultures was performed as previously described 8 using rat polyclonal antibodies against Cryptosporidium and biotin-SP-conjugated anti-rat IgG and IgM (heavy and light chain) goat F(abЈ) 2 fragments 2 mg/L (Jackson Immunoresearch, Westgrove, PE, USA) as secondary antibody revealed using alkaline phosphatasecoupled avidin (ABC Reagent; Vector Laboratories, Burlingame, CA, USA).
Inhibitory activities of agents are expressed as percentages, the per cent inhibition was defined as The MIC 50 was defined as the concentration (in mg/L of culture) of agent that resulted in a 50% inhibition of C. parvum development.
The cytotoxicities of nitazoxanide, tizoxanide and tizoxanide glucuronide were determined using trypan blue exclusion and nitroblue tetrazolium chloride monohydrate reduction assays (CellTiter 96 AQ ueous non-radioactive cell proliferation assay; Promega, Madison, WI, USA). Controls included infected and uninfected cells in culture medium. Results were expressed as the decrease in absorbance at 450 nm (A 450 ) expressed as percentages of the A 450 values in control cultures. From preliminary studies we verified that HCT-8 cell cytotoxicity was minimal (decrease of A 450 from 0 to 14%) for all controls and at all concentrations of agents, except nitazoxanide at 25 and 50 mg/L (A 450 decrease of 36% and 39%, respectively).
A In the EIA, background A 405 , resulting from the intense colour of the solutions, was higher in uninfected wells exposed to drugs than in control wells without agent, and for this reason they were used as controls for infected wells containing the same agent concentration. In addition, disruption of infected monolayers and/or peeling off of HCT-8 cells occurred during EIA in wells containing tizoxanide or tizoxanide glucuronide at 10-50 mg/L. For tizoxanide and tizoxanide glucuronide, high background A 405 was observed at concentrations of Ͼ50 mg/L, preventing any conclusions from being drawn.
The effects of nitazoxanide, tizoxanide and tizoxanide glucuronide on the various stages of the C. parvum life cycle were studied by adding the tested compounds, at concentrations ranging from 1 to 50 mg/L, at the start of the culture (sporozoite stage), 2 h after adding sporozoites (trophozoite stage) and 18 h after adding sporozoites (sexual stages).
Results
The effects of nitazoxanide, tizoxanide and tizoxanide glucuronide on the asexual and sexual stages of parasite development were investigated by exposure to the agents for 46 h starting 2 h after adding sporozoites (Figure 1 and Table) . To test the effects of agents on penetration of sporozoites into HCT-8 cells, the agents were added at the same time as sporozoites, and culture supernatants were removed and replaced by agent-free medium 2 h later; EIA detection of parasite development was performed after a further 46 h incubation. Nitazoxanide and tizoxanide were active during the sporozoite penetration stage, while the effect of tizoxanide glucuronide appeared limited (Figure 2 and Table) . The effects on asexual or sexual development were investigated by adding agents for 4 h, 2 h after adding sporozoites (for asexual development) or 18 h after adding sporozoites (for sexual development). As shown in Figure  3 and the Table, nitazoxanide inhibited asexual development more than tizoxanide glucuronide, while tizoxanide had no significant effect. Figure 4 and the Table depict the marked inhibitory effect of tizoxanide glucuronide on sexual stages, and the lesser effects of nitazoxanide and tizoxanide.
Discussion
In this study, nitazoxanide was found to be highly effective in vitro against the development of the asexual and sexual stages of C. parvum. This is in agreement with a previous study which found that nitazoxanide inhibits C. parvum development. 12 Our findings, which indicate that tizoxanide glucuronide inhibits parasite development, suggest that nitazoxanide activity is at least in part due to this metabolite. Interestingly, nitazoxanide and tizoxanide appear to be more active against the extracellular sporozoite stage, whereas tizoxanide glucuronide acts primarily on intracellular development. This was confirmed using simultaneous immunofluorescent assays (data not shown). Whether this is because tizoxanide glucuronide is better at penetrating the cell membrane requires additional investigation.
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Previous clinical studies have shown that nitazoxanide is clinically active against cryptosporidiosis. 13, 14 This compound has a wide range of antimicrobial activities, particularly against intestinal protozoa and helminths. 15 Present data underline the potential interest in nitazoxanide metabolites as candidates for in vivo studies. Interestingly, studies in an immunosuppressed rat model suggest that relapses are less frequent after treatment with nitazoxanide than with the non-absorbable paromomycin and sinefungin (Li, X., unpublished results). Taken together, these data indicate the need for additional studies on the biliary clearance of nitazoxanide metabolites and their potential activity on biliary tract cryptosporidiosis.
